Tag: Betalutin

Nordic Nanovector initiates Betalutin rituximab combo trial in 2L FL

pharmanewsdaily- November 4, 2018

Nordic Nanovector has announced the dosing of the first patient in a phase 1b clinical trial called Archer-1 for evaluating the combination of its investigational ... Read More

Nordic Nanovector initiates mid-stage trial of Betalutin in 3L Follicular Lymphoma in US

pharmanewsdaily- October 28, 2018

Nordic Nanovector has opened its first clinical site in the US at Long Beach in California for the PARADIGME trial to evaluate its tumor-seeking anti-CD37 ... Read More